CEO
BrYet US, Inc.
This biotech company focuses on the discovery and development of cancer therapies utilizing transport econophysics specifically for metastatic liver and lung cancer. By providing targeted treatment options, it enables healthcare professionals to improve patient outcomes in these challenging cancer types.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$200KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- This biotech company focuses on the discovery and development of cancer therapies utilizing transport econophysics specifically for metastatic liver and lung cancer. By providing targeted treatment options, it enables healthcare professionals to improve patient outcomes in these challenging cancer types.